Antibody drug conjugates (ADCs) are innovative cancer therapies that combine the specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic drugs, targeting cancer cells more precisely. However, the use of ADCs may be associated with ocular side effects, ranging from mild symptoms such as blurred vision to more severe complications like retinal toxicity, highlighting the need for careful monitoring and management in clinical practice.

Read more!

Age-related macular degeneration (AMD) is a progressive eye condition that predominantly affects individuals over the age of 50, gradually leading to central vision loss. As one of the leading causes of vision impairment among older adults, AMD primarily targets the macula, the central portion of the retina responsible for sharp and detailed vision. Early detection and timely management are crucial in mitigating the impact of AMD on visual function.

“Dry eye is a multi-factoral disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles”

DEWS2 STUDY

Optical coherence tomography (OCT) is a noninvasive diagnostic tool for practitioners, utilizing light waves to provide cross-section imaging of the retina. The OCT provides invaluable data within minutes that allows the practitioner to quickly and accurately diagnose patients. The technology has advanced tremendously over the years and has allowed for improved patient care on both ends.

Read more!